Clinical Trials Update: March 26, 2008
Rheumatoid Arthritis Breast Cancer Sarcoma
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will evaluate an investigational drug in people with active rheumatoid arthritis who are taking a stable dose of methotrexate.
The study is at various sites in Michigan.
If you are 18 or older, have breast cancer with locally recurrent or metastatic disease, and are HER2-positive, you may qualify for this study.
The research site is in Crestview Hills, Ky.
If you or your child are 12 or older and have a qualifying type of sarcoma cancer, you or the child may be eligible for this study.
The research site is in West Hollywood, Calif.
Copyright 2008 Thomson CenterWatch. All rights reserved.